TokenPost·

Novartis Says AI Could Cut Drug Development From 12 Years to Eight

Your call?

CEO Vasant Narasimhan said AI is speeding candidate discovery and clinical operations. Novartis is targeting a higher success rate for drugs entering human testing.

Share

More news